Effect of empagliflozin on cardiac biomarkers in a zebrafish model of heart failure: clues to the EMPA-REG OUTCOME trial?
Page 1 of 1
Effect of empagliflozin on cardiac biomarkers in a zebrafish model of heart failure: clues to the EMPA-REG OUTCOME trial?
Shi X, Verma S, Yun J, Brand-Arzamendi K, Singh KK, Liu X, Garg A, Quan A, Wen XY. Effect of empagliflozin on cardiac biomarkers in a zebrafish model of heart failure: clues to the EMPA-REG OUTCOME trial? Mol Cell Biochem. 2017 Apr 8. doi: 10.1007/s11010-017-3018-9. [Epub ahead of print]
Similar topics
» RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure
» Cardiac CD47 Drives Left Ventricular Heart Failure Through Ca2+‐CaMKII‐Regulated Induction of HDAC3
» Atrogin-1 Deficiency Leads to Myopathy and Heart Failure in Zebrafish
» Effect of Tbx1 knock-down on cardiac performance in zebrafish
» Orai1 deficiency leads to heart failure and skeletal myopathy in zebrafish
» Cardiac CD47 Drives Left Ventricular Heart Failure Through Ca2+‐CaMKII‐Regulated Induction of HDAC3
» Atrogin-1 Deficiency Leads to Myopathy and Heart Failure in Zebrafish
» Effect of Tbx1 knock-down on cardiac performance in zebrafish
» Orai1 deficiency leads to heart failure and skeletal myopathy in zebrafish
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum